Literature DB >> 28343552

Testosterone in Women: Measurement and Therapeutic Use.

Ann Kathryn Korkidakis1, Robert L Reid2.   

Abstract

Androgens, both in excessive and depleted states, have been implicated in female reproductive health disorders. As such, serum testosterone measurements are frequently ordered by physicians in cases of sexual dysfunction and in women presenting with hirsutism. Commercially available androgen assays have significant limitations in the female population. Furthermore, the measurements themselves are not always informative in patient diagnosis, treatment, or prognosis. This article reviews the limitations of serum androgen measurements in women suspected to have elevated or reduced androgen action. Finally, we consider when therapeutic use of androgen replacement may be appropriate for women with sexual interest/arousal disorders.
Copyright © 2017 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hirsutism; androgen assays; libido; polycystic ovary syndrome

Mesh:

Substances:

Year:  2017        PMID: 28343552     DOI: 10.1016/j.jogc.2017.01.006

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  2 in total

1.  Dehydroepiandrosterone and cortisol as markers of HPA axis dysregulation in women with low sexual desire.

Authors:  Rosemary Basson; Julia I O'Loughlin; Joanne Weinberg; Allan H Young; Tamara Bodnar; Lori A Brotto
Journal:  Psychoneuroendocrinology       Date:  2019-03-08       Impact factor: 4.905

2.  The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization.

Authors:  Kelsey Hazegh; Marjorie D Bravo; Hany Kamel; Larry Dumont; Tamir Kanias
Journal:  Transfusion       Date:  2020-03-16       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.